Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

AQB vs CALM: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CALM Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 10–0 Matrix Metrics)

CALM Overall Winner 6-Pillar Tally: AQB 0 – 6 CALM Matrix Metrics: AQB 0 – 10 CALM

As of Nov 17, 2026, Cal-Maine Foods Inc (CALM) is the stronger overall head-to-head candidate over AquaBounty Technologies, Inc. (AQB) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AQB carries a Unified Composite Score of 44.6/100 (HOLD) at $0.82 (N/M Forward P/E, 0.0% operating margin), whereas CALM carries 46.3/100 (HOLD) at $65.24 (26.9x Forward P/E, 0.8% operating margin).

  • Technical & Structure Timing Caution: AQB is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 37.5); meanwhile CALM is in a Weinstein Distribution regime near a flattening 50-day moving average and Breakdown options structure phase (RSI 48.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About AQB vs CALM
AQB NASDAQ
AquaBounty Technologies, Inc.
Fishing, Hunting And Trapping
$0.82
+2.01% 1D
Market Cap $9.7M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.93β · 117% Vol
Unified Composite Score
44.6 / 100 HOLD
Tech 33.0 Fund 49.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.5%), weak momentum, RSI 37
RSI-14: 37.5 · SMA20: $1.04 · SMA50: $1.03
CALM NASDAQ Head-to-Head Winner
Cal-Maine Foods Inc
Agricultural Prod-Livestock & Animal Specialties
$65.24
-1.95% 1D
Market Cap $3.1B
TTM Revenue $2.53B
Forward P/E 26.9x
Beta / 30D Vol 0.02β · 44% Vol
Unified Composite Score
46.3 / 100 HOLD
Tech 54.0 Fund 54.0 Flow 57.0 Mom 50.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -8.6%) with fading momentum, RSI 49
RSI-14: 48.7 · SMA20: $64.71 · SMA50: $66.72

6-Pillar Scorecard Institutional Category Breakdown (AQB 0 – 6 CALM)

Columns: Metric · AQB · CALM
1. Valuation Multiples CALM
Forward P/E N/M 26.9x
Trailing P/E N/M 54.1x
PEG Ratio N/M 2.20x
EV / Revenue N/M 1.2x
2. Growth & Scale CALM
Revenue Growth (YoY) -93.5% -41.5%
Earnings Growth (YoY) +0.0% -89.8%
TTM Revenue (USD) N/A $2.53B
Market Cap $9.7M $3.1B
3. Profitability & Quality CALM
Gross Margin N/A 14.3%
Operating Margin 0.0% 0.8%
Net Profit Margin 0.0% 2.3%
Return on Equity (ROE) -68.9% 2.4%
4. Balance Sheet & Cash Flow CALM
Cash Generation (TTM) -$7.2M -$58M
Cash Flow Margin N/A -2.3%
Net Cash / Leverage $0.19 Book/Sh · -68.9% ROE $54.77 Book/Sh · 2.4% ROE
Dividend Yield None (0.00%) 1.63%
5. Options & Positioning CALM
Options Structure Phase BREAKDOWN BREAKDOWN
Current IV / %ile N/A (N/A) 37.7% (19th %ile)
Put/Call OI Skew N/A 0.41x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markdown DISTRIBUTION · Distribution
6. R&D & Supply-Chain Moat CALM
OpEx & R&D Intensity N/A 13.5% of Rev ($341M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Farm Products Operator Farm Products Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: AQB (0) vs CALM (10)
Institutional Metric AQB CALM Criterion Row Edge
Market Capitalization
Scale
$9.7M $3.1B Larger Scale CALM
Trailing P/E Ratio
Valuation
N/M 54.1x Lower Multiple CALM
Forward P/E Ratio
Valuation
N/M 26.9x Lower Multiple CALM
Revenue Growth (YoY)
Growth
-93.5% -41.5% Higher Growth CALM
Operating Margin (TTM)
Profitability
0.0% 0.8% Higher Margin CALM
Net Profit Margin
Profitability
0.0% 2.3% Higher Margin CALM
Return on Equity (ROE)
Capital Efficiency
-68.9% 2.4% Higher ROE CALM
52-Week Range Position
Momentum
11% ($1–$2) 15% ($60–$95) Stronger Trend CALM
Beta / 30D Volatility
Risk Regime
0.93β · 117% Vol 0.02β · 44% Vol Lower Realized Risk CALM
Unified Institutional Score
Composite Signal
44.6 / 100 (HOLD) 46.3 / 100 (HOLD) Higher Composite CALM
Trailing 12M Revenue (USD)
Operating Scale
N/A $2.53B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 14.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev 2.20x PEG · 1.2x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$7.2M ($0.19 Book/Sh · -68.9% ROE) -$58M ($54.77 Book/Sh · 2.4% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CALM +26.53 pp
AQB: -21.37% · CALM: +5.16%
3M Horizon CALM +19.5 pp
AQB: -38.51% · CALM: -19.01%
6M Horizon CALM +4.4 pp
AQB: -21.37% · CALM: -16.97%
1Y Horizon AQB +4.32 pp
AQB: -23.57% · CALM: -27.89%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period AQB Revenue CALM Revenue AQB Op. Margin CALM Op. Margin Margin Leader
FY2019 $0M $1.36B -7057.3% 3.4% CALM
FY2020 $0M $1.35B -12727.1% 0.1% CALM
FY2021 $0M $1.35B -1883.0% -1.9% CALM
FY2022 $0M $1.78B -711.6% 8.1% CALM
FY2023 $0M $3.15B -552.9% 30.8% CALM
FY2024 N/A $2.33B N/A 13.4% CALM
FY2025 N/A $4.26B N/A 36.1% CALM
FY2026 N/A $2.91B N/A 12.0% CALM

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
AQB BREAKDOWN
69d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AQB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CALM BREAKDOWN
78d in phase · OBV DISTRIBUTION
Current IV 37.7%
IV Percentile 19th %ile
Put/Call OI Skew 0.41x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact CALM Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
AQB Moat Profile Cyclical / Execution-Driven Positioning
Farm Products Operator
Competes within the Farm Products value chain with $9.7M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
CALM Moat Profile Cyclical / Execution-Driven Positioning
Farm Products Operator
Competes within the Farm Products value chain with $3.1B market capitalization and 0.8% operating margin.
OpEx & R&D Reinvestment 13.5% of Rev ($341M)
90D Engineering Disclosures 0 Published

Investor FAQ AQB vs CALM Key Questions & Quantitative Answers

As of Nov 17, 2026, Cal-Maine Foods Inc (CALM) is the stronger overall head-to-head candidate over AquaBounty Technologies, Inc. (AQB) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AQB carries a Unified Composite Score of 44.6/100 (HOLD) at $0.82 (N/M Forward P/E, 0.0% operating margin), whereas CALM carries 46.3/100 (HOLD) at $65.24 (26.9x Forward P/E, 0.8% operating margin). Technical & Structure Timing Caution: AQB is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 37.5); meanwhile CALM is in a Weinstein Distribution regime near a flattening 50-day moving average and Breakdown options structure phase (RSI 48.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CALM leads the Growth & Scale pillar: AQB posts -93.5% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with CALM at -41.5% YoY revenue growth and -89.8% YoY earnings growth on $2.53B TTM revenue (14.3% gross margin, 0.8% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), AQB cumulative revenue shifted N/A while CALM shifted +114.0%. In operating R&D and SG&A reinvestment, AQB deploys N/A (0 90-day corporate R&D disclosures) versus 13.5% of Rev ($341M) (0 disclosures) for CALM.

CALM screens cheaper on headline valuation multiples. AQB trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin), whereas CALM trades at 26.9x Forward P/E, 54.1x Trailing P/E, 2.20x PEG, and 1.2x EV/Revenue (-2.3% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AQB (-68.9% ROE) versus CALM (2.4% ROE) capital efficiency.

In options market volatility and institutional positioning, AQB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (0.93β · 117% Vol realized risk). By comparison, CALM carries 37.7% implied volatility (19th %ile, Compressed (<25th %ile)), a 0.41x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (0.02β · 44% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.